TARVEQDYS Trademark

Trademark Overview


On Tuesday, May 5, 2020, a trademark application was filed for TARVEQDYS with the United States Patent and Trademark Office. The USPTO has given the TARVEQDYS trademark a serial number of 88902188. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 2, 2022. This trademark is owned by Pfizer Inc.. The TARVEQDYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy
tarveqdys

General Information


Serial Number88902188
Word MarkTARVEQDYS
Filing DateTuesday, May 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 2, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, May 2, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 2, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 2 GRANTED
Monday, September 13, 2021SOU EXTENSION 2 FILED
Monday, September 13, 2021TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 1 GRANTED
Friday, February 26, 2021SOU EXTENSION 1 FILED
Friday, February 26, 2021TEAS EXTENSION RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 23, 2020ASSIGNED TO EXAMINER
Sunday, May 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 8, 2020NEW APPLICATION ENTERED IN TRAM